Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulijikere Kuerban

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Cancer Drug Targets|July 14, 2025
Identification of AR-targeted Active Compounds from Euphorbia humifusa Willd for the Treatment of Prostate CancerMireguli Abulimiti, Mourboul Ablise, Jialu Hu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
3,3'-Di-O-methylellagic Acid Isolated from <i>Euphorbia humifusa</i> Willd Suppresses Prostate Cancer Cell Viability via Regulating VDAC1 Protein ExpressionGulijikere Kuerban, Xinling Wang, Chengjing Shen, et al.
Biomedicines|May 27, 2026
In Vitro Cell Viability and Migration Inhibitory Effects of Isorhamnetin in Non-Small Cell Lung Cancer CellsChengjing Shen, Taierpuke Maimaiti, Gulijikere Kuerban, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Cancer Drug Targets|July 14, 2025
Identification of AR-targeted Active Compounds from Euphorbia humifusa Willd for the Treatment of Prostate CancerMireguli Abulimiti, Mourboul Ablise, Jialu Hu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
3,3'-Di-O-methylellagic Acid Isolated from <i>Euphorbia humifusa</i> Willd Suppresses Prostate Cancer Cell Viability via Regulating VDAC1 Protein ExpressionGulijikere Kuerban, Xinling Wang, Chengjing Shen, et al.
Biomedicines|May 27, 2026
In Vitro Cell Viability and Migration Inhibitory Effects of Isorhamnetin in Non-Small Cell Lung Cancer CellsChengjing Shen, Taierpuke Maimaiti, Gulijikere Kuerban, et al.
Pageof 1